Cleared Special

K110953 - VISENSIA, VISENSIA WITH ALERT

K110953 is an FDA 510(k) clearance for VISENSIA, manufactured by Obs Medical. The device is a Class 2 Cardiovascular device with product code MHX cleared through the Special 510(k) pathway after a 71-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2011
Decision
71d
Days
Class 2
Risk

K110953 is an FDA 510(k) clearance for the VISENSIA, VISENSIA WITH ALERT. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Obs Medical (In The Vale Oxford, GB). The FDA issued a Cleared decision on June 15, 2011 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Obs Medical devices

FDA 510(k) Submission Details - K110953

510(k) Number K110953 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 2011
Decision Date June 15, 2011
Days to Decision 71 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 125d · This submission: 71d
Pathway characteristics
Modification to existing cleared device.

MHX Device Classification - Class 2, Special Controls

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 352
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K110953.
SPACELABS HEALTHCARE XPREZZON BESIDE MONITOR(9913930)
K112962 · Spacelabs Medical, Inc. · Nov 2011
PATIENT MONITOR
K112803 · Guangdong Biolight Meditech Co., Ltd. · Oct 2011
PATIENT MONITOR
K110922 · Edan Instruments, Inc. · Jul 2011
INTELLIVUE PATIENT MONITOR
K110622 · Philips Medizinsysteme Boeblingen GmbH, Cardiac AN · Mar 2011
FUKUDA DENSHI
K103134 · Fukuda Denshi USA, Inc. · Mar 2011
SPACELABS MEDICAL PATIENT MONITORS
K102422 · Spacelabs Medical, Inc. · Dec 2010